|
|
.
ICD-10 (CM) Code and Descriptor
|
B99.9 |
Unspecified infectious disease
|
B999 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.12%
|
24.91%
|
13.01%
|
8.42%
|
4.57%
|
2.97%
|
2.21%
|
1.61%
|
1.08%
|
0.84%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for B99.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,268
|
4,270
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,176
|
3,198
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,617
|
2,617
|
|
86140
|
C-REACTIVE PROTEIN |
2,423
|
2,426
|
|
87070
|
CULTURE OTHR SPECIMN AEROBIC |
2,076
|
2,115
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
2,002
|
2,007
|
|
87205
|
SMEAR GRAM STAIN |
1,613
|
1,641
|
|
85652
|
RBC SED RATE AUTOMATED |
1,418
|
1,418
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
1,355
|
1,685
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,343
|
1,350
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
1,312
|
1,757
|
|
J0696
|
CEFTRIAXONE SODIUM INJECTION |
1,050
|
7,727
|
|
80048
|
METABOLIC PANEL TOTAL CA |
977
|
977
|
|
J0878
|
DAPTOMYCIN INJECTION |
909
|
464,998
|
|
96374
|
THER/PROPH/DIAG INJ IV PUSH |
858
|
858
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
846
|
18,716
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
746
|
1,526
|
|
J1335
|
ERTAPENEM INJECTION |
744
|
1,445
|
|
85651
|
RBC SED RATE NONAUTOMATED |
695
|
695
|
|
80202
|
ASSAY OF VANCOMYCIN |
639
|
644
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
B99.9 related to the following DRG Codes:
867-869
|
